JnJ seeks USFDA nod for Tremfya for treatment of plaque psoriasis, juvenile psoriatic arthritis in children Ruchika Sharma3 Dec 2024 12:30 PM ISTSpring House: Johnson & Johnson has announced the submission of two supplemental Biologics License Applications (sBLAs) to the U.S. Food and...
USFDA approves Biocon Biologics Yesintek for Crohn's disease, Ulcerative Colitis, Plaque Psoriasis, Psoriatic Arthritis Ruchika Sharma2 Dec 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the U.S. Food ...
Icotrokinra shows impressive results in moderate to severe plaque psoriasis in phase 3 trial Dr. Kamal Kant Kohli23 Nov 2024 6:00 AM ISTIcotrokinra is an investigational oral peptide that blocks interleukin (IL)-23 receptor, which plays a significant role in the pathogenesis of...
Biocon Biologics announces New Dermatology data to be presented at EADV Congress 2024 Ruchika Sharma25 Sept 2024 2:48 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd has announced new dermatology data presented at the European Academy of...
Submit safety data on South Asian subjects with Plaque Psoriasis: CDSCO Panel Tells Johnson & Johnson on Ustekinumab Dr. Divya Colin24 Sept 2024 6:00 PM ISTNew Delhi: In line with the proposal presented by the drug major Johnson and Johnson proposal for approval of additional indication with waiver of...
Zasocitinib therapy highly efficacious for treatment of severe plaque psoriasis: JAMA Jacinthlyn Sylvia2 Sept 2024 2:00 AM ISTA recent study published in the Journal of American Medical Association revealed that Zasocitinib could be a breakthrough in the treatment of moderate...
Biocon Biologics secures market entry for Bmab 1200 in Europe, UK, Canada, Japan Ruchika Sharma29 Aug 2024 12:30 PM ISTBangalore: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd, announced today that the...
Sandoz unveils biosimilar Pyzchiva across Europe to treat chronic inflammatory diseases Ruchika Sharma28 July 2024 10:30 AM ISTBasel: Sandoz has announced the launch of Pyzchiva (ustekinumab) across Europe. Pyzchiva, developed and registered by Samsung Bioepis, a ustekinumab...
Piclidenoson efficacious and safe in the treatment of patients with plaque psoriasis: Study Dr. Shravani Dali13 July 2024 4:45 AM ISTPiclidenoson is efficacious and safe in the treatment of patients with plaque psoriasis suggests a study published in the Journal of the European...
Plaque Psoriasis highly prevalent among patients with MASLD and lean MASLD, suggests study Dr Riya Dave13 Jun 2024 8:00 PM ISTResearchers have found that metabolic dysfunction-associated steatotic liver disease (MASLD) and lean MASLD are highly prevalent among patients with...
Lupin unveils Rymti biosimilar Etanercept in Canada Ruchika Sharma5 May 2024 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Rymti, Lupin's first biosimilar in Canada, through its partner Sandoz...
Conduct bridging CT, prove efficacy, safety: CDSCO Panel Tells Glenmark on Roflumilast Cream of additional strength, indication Dr. Divya Colin30 April 2024 6:00 PM ISTNew Delhi: Citing that Glenmark Limited should conduct bridging clinical trials to prove the efficacy and safety of the Roflumilast Cream 0.3%w/w...
